Active Ingredient History
L-arginine is a nonessential amino acid that may play an important role in the treatment of cardiovascular disease due to its antiatherogenic, anti-ischemic, antiplatelet, and antithrombotic properties. It has been promoted as a growth stimulant and as a treatment for erectile dysfunction in men. L-arginine is a nonessential amino acid that may play an important role in the treatment of heart disease due to its block arterial plaque buildup, blood clots, platelet clumping, and to increase blood flow through the coronary artery. L-arginine is commonly sold as a health supplement claiming to improve vascular health and treat erectile dysfunction in men. L-arginine, which is promoted as a human growth stimulant, has also been used in bodybuilding. In the 1800s, it was first isolated from animal horn. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Kidney Injury (Phase 4)
Adipose Tissue, Brown (Phase 3)
Alzheimer Disease (Phase 2)
Amino Acid Metabolism, Inborn Errors (Phase 2)
Anemia, Sickle Cell (Phase 3)
Antioxidants (Phase 4)
Argininosuccinic Aciduria (Phase 2)
Arterial Occlusive Diseases (Phase 4)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 2)
Ataxia Telangiectasia (Phase 4)
Atherosclerosis (Phase 4)
beta-Thalassemia (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Cardiovascular Diseases (Phase 3)
Chromosome Aberrations (Phase 3)
Chronic Limb-Threatening Ischemia (Phase 4)
Coronary Artery Disease (Phase 1/Phase 2)
COVID-19 (Phase 2)
Critical Illness (Phase 4)
Cystic Fibrosis (Phase 2)
Dental Caries (Phase 2)
Dentin Sensitivity (Phase 4)
Diabetes Mellitus (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Foot (Phase 2/Phase 3)
Dystrophin (Phase 1)
Endothelial Cells (Phase 3)
Enterocolitis, Necrotizing (Phase 2/Phase 3)
Erectile Dysfunction (Phase 4)
Essential Hypertension (Phase 2/Phase 3)
Fetal Growth Retardation (Phase 4)
Fibrosis (Phase 2/Phase 3)
Galactosemias (Phase 2)
Glioblastoma (Phase 1)
Glucose Intolerance (Phase 3)
Growth and Development (Phase 4)
Growth Hormone (Phase 3)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 4)
Heart Defects, Congenital (Phase 2/Phase 3)
Heart Disease Risk Factors (Phase 1)
Heart Failure (Phase 3)
Heart Transplantation (Phase 4)
Heart Ventricles (Phase 2/Phase 3)
Hepatitis ()
Hepatitis, Alcoholic (Phase 2)
Hypercholesterolemia (Phase 2)
Hypertension (Phase 3)
Hypertension, Pregnancy-Induced (Phase 3)
Infertility, Male (Phase 4)
Inflammation (Phase 2)
Insulin Resistance (Phase 3)
Insulin Secretion (Phase 4)
Intermittent Claudication (Phase 1)
Intestinal Neoplasms (Phase 1)
Ischemia (Phase 4)
Kidney Diseases (Early Phase 1)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 1)
Liver Cirrhosis (Phase 2/Phase 3)
Liver Neoplasms (Phase 2/Phase 3)
Lymphoid Tissue (Phase 2)
Lymphoma (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Malaria, Falciparum (Phase 2)
MELAS Syndrome (Phase 2)
Metabolic Syndrome (Phase 3)
Mitochondrial Diseases (Phase 4)
Muscle Fatigue (Phase 4)
Muscles (Phase 4)
Muscular Dystrophy, Duchenne (Phase 1)
Myocardium (Phase 4)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 3)
Nitric Oxide (Phase 3)
Pain (Phase 2)
Pancreatic Neoplasms (Phase 4)
Perfusion (Phase 2/Phase 3)
Periodontitis (Phase 3)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 1)
Pneumonia (Phase 2)
Post-Cardiac Arrest Syndrome (Phase 3)
Postmenopause (Phase 2)
Precancerous Conditions (Phase 1)
Pre-Eclampsia (Phase 3)
Pregnancy, High-Risk (Phase 2)
Prostatic Neoplasms (Phase 2)
Renal Dialysis (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Schizophrenia (Phase 2)
Semen Analysis (Phase 4)
Sepsis (Phase 2/Phase 3)
Shock, Septic (Early Phase 1)
Skin Care (Early Phase 1)
Skin Ulcer (Phase 2)
Spirometry (Phase 4)
Thalassemia (Phase 4)
Tooth Bleaching (Phase 4)
Tuberculosis (Phase 3)
Urea Cycle Disorders, Inborn (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Diseases (Phase 3)
Vasoconstriction (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue